Orchestra BioMed Holdings Growth Metrics (2022-2025) | OBIO

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -28063.0063,369.00-228942.00-398212.00-122895.00-73274.00162,285.00-153676.00869.00-26275.00-86502.00
EBITDA Margin Growth (3y) -150090.00-36180.00-153159.00
EBITDA Margin (QoQ) -129531.00107,276.00-59.00-5750.00-38099.00-185034.00-169329.00269,566.0011,522.0050,525.00-485290.00424,111.00-15622.00-9702.00
EBIT Margin Growth (1y) -39969.0048,778.00-260074.00-387272.00-133445.00-75101.00181,062.00-182796.0014,645.00-14488.00-70351.00
EBIT Margin Growth (3y) -158769.00-40810.00-149363.00
EBIT Margin (QoQ) -131159.00103,813.00-2542.00-10081.00-42412.00-205039.00-129739.00243,745.0015,932.0051,124.00-493598.00441,186.00-13200.00-4739.00
EBT Margin Growth (1y) -39969.0048,778.00-238237.00-344982.00-117058.00-63507.00168,505.00-204454.00171.00-26512.00-85613.00
EBT Margin Growth (3y) -156857.00-41241.00-155344.00
EBT Margin (QoQ) -131159.00103,813.00-2542.00-10081.00-42412.00-183202.00-109287.00217,842.0011,139.0048,811.00-482246.00422,466.00-15543.00-10290.00
Enterprise Value Growth (1y) 81.11%-82.99%7.82%16.02%-78.28%470.02%-17.11%-72.55%16.56%-45.35%-93.86%
Enterprise Value Growth (3y) -22.89%-19.07%-62.01%
Enterprise Value (QoQ) 0.56%-45.51%44.41%128.89%-90.55%245.26%55.40%-57.16%147.99%-49.79%-48.55%81.94%16.27%-94.36%
FCF Margin Growth (1y) -61828.0090,322.00-181531.00-338976.00-89393.00-16345.00106,354.00-120548.0020,523.00-54851.00-33097.00
FCF Margin Growth (3y) -130698.0019,125.00-108274.00
FCF Margin (QoQ) -143241.00140,945.00-15448.00-44085.008,909.00-130907.00-172893.00205,499.0081,957.00-8208.00-399795.00346,570.006,583.0013,546.00
Gross Margin Growth (1y) 107.00906.00-497.00-1313.00-170.0025.00290.00-499.0041.0015.00120.00
Gross Margin Growth (3y) -22.00946.00-88.00
Gross Margin (QoQ) -1011.001,015.001.00103.00-212.00-388.00-815.001,246.00-17.00-123.00-1604.001,786.00-43.00-19.00
Net Margin Growth (1y) -39969.0048,778.00-238237.00-344982.00-117058.00-63507.00168,505.00-204454.00171.00-26512.00-85613.00
Net Margin Growth (3y) -156857.00-41241.00-155344.00
Net Margin (QoQ) -131159.00103,813.00-2542.00-10081.00-42412.00-183202.00-109287.00217,842.0011,139.0048,811.00-482246.00422,466.00-15543.00-10290.00
Operating Margin Growth (1y) -39969.0048,778.00-260074.00-387272.00-133445.00-75101.00181,062.00-182796.0014,645.00-14488.00-70351.00
Operating Margin Growth (3y) -158769.00-40810.00-149363.00
Operating Margin (QoQ) -131159.00103,813.00-2542.00-10081.00-42412.00-205039.00-129739.00243,745.0015,932.0051,124.00-493598.00441,186.00-13200.00-4739.00
Return on Assets Growth (1y) -7.00-24.00-36.00-36.00-34.00-40.00-67.00-26.00
Return on Assets (QoQ) 6.000.00-6.00-7.00-11.00-12.00-6.00-4.00-18.00-39.0035.00
Return on Capital Employed Growth (1y) -3.00-32.00-55.00-55.00-54.00-63.00-118.00-37.00
Return on Capital Employed (QoQ) 14.000.00-12.00-5.00-15.00-23.00-12.00-4.00-24.00-78.0069.00
Return on Equity Growth (1y) 74.00-31.00-60.00-68.00-87.00-184.00-705.00-217.00
Return on Equity (QoQ) 89.004.00-10.00-10.00-15.00-25.00-17.00-30.00-112.00-547.00472.00
Return on Sales Growth (1y) -869.00-1297.00-1592.00-791.00-517.0020.00247.00-543.00
Return on Sales (QoQ) -96.00-2.00-309.00-462.00-524.00-297.00492.00-189.0013.00-70.00-298.00